Holiday notice

BioWorld's offices will be closed in observance of Christmas. No issue will be published Tuesday, Dec. 26.

To read more on related topics, click on one of the words below.

BioWorld Asia

Today's news in brief

BioWorld

BioWorld briefs for Oct. 4, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for October 4, 2024.

Karxt for schizophrenia awaits US FDA decision; inventor opines

BioWorld

Nine years on from securing $3.84 million for a phase I clinical trial to test the formulation, with results showing it overcame side effects that had confounded...

Axcynsis Therapeutics patents new ADCs for treatment of cancer

BioWorld Science

Work at Axcynsis Therapeutics Pte. Ltd. has led to the creation of antibody-drug conjugates (ADCs) comprising antibodies covalently linked to ecteinascidin and...

US FDA clears Cobenfy, first new schizophrenia drug in decades

BioWorld

The FDA has approved Cobenfy, a dual M1/M4 muscarinic agonist that offers a fundamentally different approach to treating schizophrenia. The fixed dose combination...

Upgrade your daily dose of biopharma and medtech news

Holiday notice

Related Articles